Ghost Tree Capital, LLC Kezar Life Sciences, Inc. Transaction History

Ghost Tree Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.13 - $7.31 $516,158 - $1.21 Million	-164,907 Reduced 48.52%	175,000 $547,000
Q4 2022 Feb 14, 2023	SELL	$6.39 - $8.8 $1.18 Million - $1.63 Million	-185,093 Reduced 35.26%	339,907 $2.39 Million
Q3 2022 Nov 14, 2022	BUY	$7.99 - $10.75 $599,250 - $806,250	75,000 Added 16.67%	525,000 $4.52 Million
Q2 2022 Aug 15, 2022	BUY	$4.58 - $17.13 $229,000 - $856,500	50,000 Added 12.5%	450,000 $3.72 Million
Q1 2022 May 16, 2022	BUY	$12.3 - $18.33 $1.85 Million - $2.75 Million	150,000 Added 60.0%	400,000 $6.65 Million
Q4 2021 Feb 16, 2022	BUY	$7.44 - $16.72 $1.86 Million - $4.18 Million	250,000 New	250,000 $4.18 Million

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.